OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 205
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 205
Showing 1-25 of 205 citing articles:
Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument
Harriet Louise Walker, Shahi Ghani, Christoph Kuemmerli, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e47479-e47479
Open Access | Times Cited: 171
Harriet Louise Walker, Shahi Ghani, Christoph Kuemmerli, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e47479-e47479
Open Access | Times Cited: 171
Therapeutic developments in pancreatic cancer
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 123
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 123
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 99
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 99
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 205-217
Closed Access | Times Cited: 85
Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 205-217
Closed Access | Times Cited: 85
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 60
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 60
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 24
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 24
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 22
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 22
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 20
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 20
Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer
Won‐Gun Yun, Yoon Soo Chae, Youngmin Han, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2819-2829
Open Access | Times Cited: 2
Won‐Gun Yun, Yoon Soo Chae, Youngmin Han, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2819-2829
Open Access | Times Cited: 2
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy
Thomas F. Stoop, Atsushi Oba, Yan‐Dong Wu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2417625-e2417625
Open Access | Times Cited: 10
Thomas F. Stoop, Atsushi Oba, Yan‐Dong Wu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2417625-e2417625
Open Access | Times Cited: 10
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion
Qingbo Meng, Yuting Xie, Kang Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Qingbo Meng, Yuting Xie, Kang Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
The role of microbial indole metabolites in tumor
Dingjiacheng Jia, Zheng Kuang, Liangjing Wang
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Dingjiacheng Jia, Zheng Kuang, Liangjing Wang
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer
Ingmar F. Rompen, Joseph R. Habib, Christopher L. Wolfgang, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 489-489
Open Access | Times Cited: 8
Ingmar F. Rompen, Joseph R. Habib, Christopher L. Wolfgang, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 489-489
Open Access | Times Cited: 8
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 8
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 8
Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study
Pietro Addeo, Milena Muzzolini, Christophe Laurent, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Pietro Addeo, Milena Muzzolini, Christophe Laurent, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
Thomas F. Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
JAMA Oncology (2025)
Closed Access | Times Cited: 1
Thomas F. Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
JAMA Oncology (2025)
Closed Access | Times Cited: 1
ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas—Curative Surgery in Cured Patients?
Pietro Addeo, Milena Muzzolini, Christophe Laurent, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2861-2863
Closed Access | Times Cited: 1
Pietro Addeo, Milena Muzzolini, Christophe Laurent, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2861-2863
Closed Access | Times Cited: 1
Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Controlled Trials
Anna Ho Yin Chan, Yun Zhao, Hwee Leong Tan, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Anna Ho Yin Chan, Yun Zhao, Hwee Leong Tan, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival
Erik Storrs, Prathamesh Chati, Abul Usmani, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Erik Storrs, Prathamesh Chati, Abul Usmani, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer
Casper W.F. van Eijck, Dana A. M. Mustafa, Disha Vadgama, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 311-324
Open Access | Times Cited: 18
Casper W.F. van Eijck, Dana A. M. Mustafa, Disha Vadgama, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 311-324
Open Access | Times Cited: 18
Antibody drug conjugates: hitting the mark in pancreatic cancer?
Nicole L. Wittwer, Michael P. Brown, Vasilios Liapis, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Nicole L. Wittwer, Michael P. Brown, Vasilios Liapis, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma – analysis from SWOG S1505
Davendra Sohal, Robert D. Boutin, Leon Lenchik, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 3, pp. 232-235
Closed Access | Times Cited: 7
Davendra Sohal, Robert D. Boutin, Leon Lenchik, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 3, pp. 232-235
Closed Access | Times Cited: 7
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 7
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 7
Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer
Yifan Fu, Jinxin Tao, Yani Gu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Yifan Fu, Jinxin Tao, Yani Gu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 7
